Affinity isolation of imidazoline binding proteins from rat brain using 5-amino-efaroxan as a ligand

被引:30
作者
Monks, LK
Cosgrove, KE
Dunne, MJ
Ramsden, CA
Morgan, NG [1 ]
Chan, SLF
机构
[1] Univ Keele, Cellular Pharmacol Grp, Sch Life Sci, Keele ST5 5BG, Staffs, England
[2] Univ Keele, Sch Chem & Phys, Keele ST5 5BG, Staffs, England
[3] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England
[4] Univ Sheffield, Inst Mol Physiol, Sheffield S10 2TN, S Yorkshire, England
基金
英国惠康基金;
关键词
I site; imidazoline; ATP-sensitive potassium channel; insulin secretion; efaroxan;
D O I
10.1016/S0014-5793(99)00264-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have employed an amino derivative of the imidazoline ligand, efaroxan, to isolate imidazoline binding proteins from solubilised extracts of rat brain, by affinity chromatography. A number of proteins were specifically retained on the affinity column and one of these was immunoreactive with an antiserum raised against the ion conducting pore component of the ATP-sensitive potassium channel. Patch clamp experiments confirmed that, like its parent compound, amino-efaroxan blocks ATP-sensitive potassium channels in human pancreatic beta-cells and can stimulate the insulin secretion from these cells, The results reveal that a member of the ion conducting pore component family is strongly associated with imidazoline binding proteins in brain and in the endocrine pancreas. (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:61 / 64
页数:4
相关论文
共 39 条
[1]   Toward understanding the assembly and structure of KATP channels [J].
Aguilar-Bryan, L ;
Clement, JP ;
Gonzalez, G ;
Kunjilwar, K ;
Babenko, A ;
Bryan, J .
PHYSIOLOGICAL REVIEWS, 1998, 78 (01) :227-245
[2]  
ALLAN DR, 1993, BRIT J PHARMACOL, V108, P875
[3]   Correlating structure and function in ATP-sensitive K+ channels [J].
Ashcroft, FM ;
Gribble, FM .
TRENDS IN NEUROSCIENCES, 1998, 21 (07) :288-294
[4]   A view of SUR/KIR6.X, KATP channels [J].
Babenko, AP ;
Aguilar-Bryan, L ;
Bryan, J .
ANNUAL REVIEW OF PHYSIOLOGY, 1998, 60 :667-687
[5]   EFFECTS OF IMIDAZOLINES AND DERIVATIVES ON INSULIN-SECRETION AND VASCULAR-RESISTANCE IN PERFUSED RAT PANCREAS [J].
BERDEU, D ;
GROSS, R ;
RIBES, G ;
LOUBATIERESMARIANI, MM ;
BERTRAND, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 254 (1-2) :119-125
[6]  
Bousquet P, 1995, J CARDIOVASC PHARM, V26, pS1
[7]   ANTAGONISM OF THE STIMULATORY EFFECTS OF EFAROXAN AND GLIBENCLAMIDE IN RAT PANCREATIC-ISLETS BY THE IMIDAZOLINE, RX801080 [J].
BROWN, CA ;
CHAN, SLF ;
STILLINGS, MR ;
SMITH, SA ;
MORGAN, NG .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (03) :1017-1022
[8]   Characterisation of new efaroxan derivatives for use in purification of imidazoline-binding sites [J].
Chan, SLF ;
Pallett, AL ;
Clews, J ;
Ramsden, CA ;
Chapman, JC ;
Kane, C ;
Dunne, MJ ;
Morgan, NG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 355 (01) :67-76
[9]   STIMULATION OF INSULIN-SECRETION BY EFAROXAN MAY INVOLVE INTERACTION WITH POTASSIUM CHANNELS [J].
CHAN, SLF ;
MORGAN, NG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 176 (01) :97-101
[10]   Association and stoichiometry of K-ATP channel subunits [J].
Clement, JP ;
Kunjilwar, K ;
Gonzalez, G ;
Schwanstecher, M ;
Panten, U ;
AguilarBryan, L ;
Bryan, J .
NEURON, 1997, 18 (05) :827-838